Literature DB >> 33367978

Selective toxicity of antibacterial agents-still a valid concept or do we miss chances and ignore risks?

Axel Dalhoff1.   

Abstract

BACKGROUND: Selective toxicity antibacteribiotics is considered to be due to interactions with targets either being unique to bacteria or being characterized by a dichotomy between pro- and eukaryotic pathways with high affinities of agents to bacterial- rather than eukaryotic targets. However, the theory of selective toxicity oversimplifies the complex modes of action of antibiotics in pro- and eukaryotes. METHODS AND
OBJECTIVE: This review summarizes data describing multiple modes of action of antibiotics in eukaryotes.
RESULTS: Aminoglycosides, macrolides, oxazolidinones, chloramphenicol, clindamycin, tetracyclines, glycylcyclines, fluoroquinolones, rifampicin, bedaquillin, ß-lactams inhibited mitochondrial translation either due to binding to mitosomes, inhibition of mitochondrial RNA-polymerase-, topoisomerase 2ß-, ATP-synthesis, transporter activities. Oxazolidinones, tetracyclines, vancomycin, ß-lactams, bacitracin, isoniazid, nitroxoline inhibited matrix-metalloproteinases (MMP) due to chelation with zinc and calcium, whereas fluoroquinols fluoroquinolones and chloramphenicol chelated with these cations, too, but increased MMP activities. MMP-inhibition supported clinical efficacies of ß-lactams and daptomycin in skin-infections, and of macrolides, tetracyclines in respiratory-diseases. Chelation may have contributed to neuroprotection by ß-lactams and fluoroquinolones. Aminoglycosides, macrolides, chloramphenicol, oxazolidins oxazolidinones, tetracyclines caused read-through of premature stop codons. Several additional targets for antibiotics in human cells have been identified like interaction of fluoroquinolones with DNA damage repair in eukaryotes, or inhibition of mucin overproduction by oxazolidinones.
CONCLUSION: The effects of antibiotics on eukaryotes are due to identical mechanisms as their antibacterial activities because of structural and functional homologies of pro- and eukaryotic targets, so that the effects of antibiotics on mammals are integral parts of their overall mechanisms of action.

Entities:  

Keywords:  DNA damage repair; Eukaryotic targets; Helicases; Metallo-matrix proteinases; Mitochondria; Neuroprotection; Read through; Selective toxicity

Mesh:

Substances:

Year:  2020        PMID: 33367978      PMCID: PMC7851017          DOI: 10.1007/s15010-020-01536-y

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   7.455


  303 in total

1.  Mode of action of penicillin.

Authors:  J T PARK; J L STROMINGER
Journal:  Science       Date:  1957-01-18       Impact factor: 47.728

2.  Magic bullets and moving targets: antibiotic resistance and experimental chemotherapy, 1900-1940.

Authors:  Christoph Gradmann
Journal:  Dynamis       Date:  2011       Impact factor: 0.429

3.  Water-soluble vitamins.

Authors:  D W WOOLLEY
Journal:  Annu Rev Biochem       Date:  1947       Impact factor: 23.643

4.  Paul Ehrlich: founder of chemotherapy.

Authors:  Stefan H E Kaufmann
Journal:  Nat Rev Drug Discov       Date:  2008-05       Impact factor: 84.694

Review 5.  Is Minocycline an Antiviral Agent? A Review of Current Literature.

Authors:  Sandhya Nagarakanti; Eliahu Bishburg
Journal:  Basic Clin Pharmacol Toxicol       Date:  2015-08-02       Impact factor: 4.080

Review 6.  Tetracyclines: a pleitropic family of compounds with promising therapeutic properties. Review of the literature.

Authors:  Michael O Griffin; Eduardo Fricovsky; Guillermo Ceballos; Francisco Villarreal
Journal:  Am J Physiol Cell Physiol       Date:  2010-06-30       Impact factor: 4.249

7.  New activities for old antibiotics.

Authors:  Jeffrey I Cohen
Journal:  Nat Microbiol       Date:  2018-05       Impact factor: 17.745

Review 8.  Antiviral, antifungal, and antiparasitic activities of fluoroquinolones optimized for treatment of bacterial infections: a puzzling paradox or a logical consequence of their mode of action?

Authors:  A Dalhoff
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-12-17       Impact factor: 3.267

9.  Alterations in monocyte CD16 in association with diabetes complications.

Authors:  Danqing Min; Belinda Brooks; Jencia Wong; Robert Salomon; Wensheng Bao; Brian Harrisberg; Stephen M Twigg; Dennis K Yue; Susan V McLennan
Journal:  Mediators Inflamm       Date:  2012-12-18       Impact factor: 4.711

Review 10.  The role of macrolides in asthma: current evidence and future directions.

Authors:  Ernie H C Wong; James D Porter; Michael R Edwards; Sebastian L Johnston
Journal:  Lancet Respir Med       Date:  2014-06-16       Impact factor: 30.700

View more
  7 in total

1.  Mitochondrial Side Effects of Surgical Prophylactic Antibiotics Ceftriaxone and Rifaximin Lead to Bowel Mucosal Damage.

Authors:  Bálint Baráth; Dávid K Jász; Tamara Horváth; Bence Baráth; Gergely Maróti; Gerda Strifler; Gabriella Varga; Lilla Sándor; Domonkos Perényi; Szabolcs Tallósy; Tibor Donka; Péter Jávor; Mihály Boros; Petra Hartmann
Journal:  Int J Mol Sci       Date:  2022-05-03       Impact factor: 6.208

2.  Correlation between Drug Resistance of Klebsiella Pneumonia and Antimicrobial Drug Usage.

Authors:  Anyun Liu; Jun Dai; Ru Shen; Feng Zhong; Xuehe Sheng; Houbao Huang
Journal:  Evid Based Complement Alternat Med       Date:  2022-05-09       Impact factor: 2.650

3.  Prevalence of plasmid-mediated AmpC β-lactamases among uropathogenic Escherichia coli isolates in southwestern Iran.

Authors:  Nabi Jomehzadeh; Khadijeh Ahmadi; Zahra Rahmani
Journal:  Osong Public Health Res Perspect       Date:  2021-12-01

Review 4.  The New Face of a Well-Known Antibiotic: A Review of the Anticancer Activity of Enoxacin and Its Derivatives.

Authors:  Karolina Jałbrzykowska; Alicja Chrzanowska; Piotr Roszkowski; Marta Struga
Journal:  Cancers (Basel)       Date:  2022-06-22       Impact factor: 6.575

Review 5.  Chelation in Antibacterial Drugs: From Nitroxoline to Cefiderocol and Beyond.

Authors:  Davorka Repac Antić; Marijo Parčina; Ivana Gobin; Mirna Petković Didović
Journal:  Antibiotics (Basel)       Date:  2022-08-15

6.  Relevance of the Consensus Principles for Appropriate Antibiotic Prescribing in 2022.

Authors:  Rafael Cantón; Murat Akova; Karen Langfeld; Didem Torumkuney
Journal:  J Antimicrob Chemother       Date:  2022-09-06       Impact factor: 5.758

7.  The Very First Modification of Pleuromutilin and Lefamulin by Photoinitiated Radical Addition Reactions-Synthesis and Antibacterial Studies.

Authors:  Son Thai Le; Dávid Páll; Erzsébet Rőth; Tuyen Tran; Nóra Debreczeni; Miklós Bege; Ilona Bereczki; Eszter Ostorházi; Márton Milánkovits; Pál Herczegh; Anikó Borbás; Magdolna Csávás
Journal:  Pharmaceutics       Date:  2021-11-28       Impact factor: 6.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.